Literature DB >> 28118936

Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry.

Casilda Olveira1, Alicia Padilla2, Miguel-Ángel Martínez-García3, David de la Rosa4, Rosa-María Girón5, Montserrat Vendrell6, Luis Máiz7, Luis Borderías8, Eva Polverino9, Eva Martínez-Moragón10, Olga Rajas11, Francisco Casas12, Rosa Cordovilla13, Javier de Gracia14.   

Abstract

INTRODUCTION: Bronchiectasis is caused by many diseases. Establishing its etiology is important for clinical and prognostic reasons. The aim of this study was to evaluate the etiology of bronchiectasis in a large patient sample and its possible relationship with demographic, clinical or severity factors, and to analyze differences between idiopathic disease, post-infectious disease, and disease caused by other factors.
METHODS: Multicenter, cross-sectional study of the SEPAR Spanish Historical Registry (RHEBQ-SEPAR). Adult patients with bronchiectasis followed by pulmonologists were included prospectively. Etiological studies were based on guidelines and standardized diagnostic tests included in the register, which were later included in the SEPAR guidelines on bronchiectasis.
RESULTS: A total of 2,047 patients from 36 Spanish hospitals were analyzed. Mean age was 64.9years and 54.9% were women. Etiology was identified in 75.8% of cases (post-Infection: 30%; cystic fibrosis: 12.5%; immunodeficiencies: 9.4%; COPD: 7.8%; asthma: 5.4%; ciliary dyskinesia: 2.9%, and systemic diseases: 1.4%). The different etiologies presented different demographic, clinical, and microbiological factors. Post-infectious bronchiectasis and bronchiectasis caused by COPD and asthma were associated with an increased risk of poorer lung function. Patients with post-infectious bronchiectasis were older and were diagnosed later. Idiopathic bronchiectasis was more common in female non-smokers and was associated with better lung function, a higher body mass index, and a lower rate of Pseudomonas aeruginosa than bronchiectasis of known etiology.
CONCLUSIONS: The etiology of bronchiectasis was identified in a large proportion of patients included in the RHEBQ-SEPAR registry. Different phenotypes associated with different causes could be identified.
Copyright © 2016 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bronchiectasis; Bronquiectasias; Clinical phenotype; Etiology; Etiología; Fenotipo clínico; Función pulmonar; Idiopathic; Idiopáticas; Lung function

Mesh:

Year:  2017        PMID: 28118936     DOI: 10.1016/j.arbres.2016.12.003

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  18 in total

Review 1.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 2.  Fungi in Bronchiectasis: A Concise Review.

Authors:  Luis Máiz; Rosa Nieto; Rafael Cantón; Elia Gómez G de la Pedrosa; Miguel Ángel Martinez-García
Journal:  Int J Mol Sci       Date:  2018-01-04       Impact factor: 5.923

Review 3.  Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Authors:  Martina Contarini; Amelia Shoemark; Jessica Rademacher; Simon Finch; Andrea Gramegna; Michele Gaffuri; Luca Roncoroni; Manuela Seia; Felix C Ringshausen; Tobias Welte; Francesco Blasi; Stefano Aliberti; James D Chalmers
Journal:  Multidiscip Respir Med       Date:  2018-08-09

4.  Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab.

Authors:  Giovanna E Carpagnano; Giulia Scioscia; Donato Lacedonia; Giacomo Curradi; Maria Pia Foschino Barbaro
Journal:  J Asthma Allergy       Date:  2019-03-05

5.  Brazilian consensus on non-cystic fibrosis bronchiectasis.

Authors:  Mônica Corso Pereira; Rodrigo Abensur Athanazio; Paulo de Tarso Roth Dalcin; Mara Rúbia Fernandes de Figueiredo; Mauro Gomes; Clarice Guimarães de Freitas; Fernando Ludgren; Ilma Aparecida Paschoal; Samia Zahi Rached; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

Review 6.  Short review on the diagnosis and treatment of bronchiectasis.

Authors:  Andrei Lesan; Alicia Elisabeth Lamle
Journal:  Med Pharm Rep       Date:  2019-04-25

Review 7.  Inhaled corticosteroids for bronchiectasis.

Authors:  Nitin Kapur; Helen L Petsky; Scott Bell; John Kolbe; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2018-05-16

8.  Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.

Authors:  Rosario Menéndez; Raúl Méndez; Eva Polverino; Edmundo Rosales-Mayor; Isabel Amara-Elori; Soledad Reyes; Tomás Posadas; Laia Fernández-Barat; Antoni Torres
Journal:  Respir Res       Date:  2017-09-30

Review 9.  The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.

Authors:  James D Chalmers; Megan Crichton; Pieter C Goeminne; Michael R Loebinger; Charles Haworth; Marta Almagro; Montse Vendrell; Anthony De Soyza; Raja Dhar; Lucy Morgan; Francesco Blasi; Stefano Aliberti; Jeanette Boyd; Eva Polverino
Journal:  Breathe (Sheff)       Date:  2017-09

10.  Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender.

Authors:  Gema Sánchez-Muñoz; Ana Lopez-de-Andrés; Valentín Hernández-Barrera; Rodrigo Jiménez-García; Fernando Pedraza-Serrano; Luis Puente-Maestu; Javier de Miguel-Díez
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.